Marina A. Malikova, PhD

Assistant Professor, Surgery

Marina Malikova
88 E. Newton St Newton Pavilion

Biography

Dr. Malikova graduated from the Institute of Biochemistry, Russian Academy of Science, in Moscow, Russia with a PhD in Biochemistry. She has a strong background in biomedical sciences and has completed her postdoctoral fellowship in the field of cell signaling and cell migration. She also holds a Master’s Degree in Clinical Investigation and Project Management Certification from Boston University.

In her current role as Executive Director, Dr. Malikova manages research efforts in seven divisions of the Department of Surgery at Boston Medical Center. She is responsible for clinical trials and basic biomedical research operations, risk management, strategic planning, and macro-management of research programs. She provides guidance and oversight to the Project Managers, Clinical Research Associates (CRAs), Clinical Research Coordinators (CRCs), and laboratory staff. She also provides assistance to investigators with protocol and informed consent writing, regulatory submissions, clinical trial agreements and budget development.

Other Positions

  • Executive Director, Surgical Translational Research Operations and Compliance, Boston University Chobanian & Avedisian School of Medicine

Publications

  • Published on 12/19/2023

    Vazirani A, Castagne-Charlotin M, Akpoviroro O, Malikova MA. Impact of institutional review board stipulations on turnaround time for approvals of surgical studies. World J Surg. 2024 Feb; 48(2):271-277. PMID: 38310311.

    Read at: PubMed
  • Published on 8/9/2023

    Ng JH, Yang W, Dember LM. Performance Characteristics of Candidate Criteria for Hemodialysis Arteriovenous Fistula Maturation. Clin J Am Soc Nephrol. 2023 Oct 01; 18(10):1321-1332. PMID: 37553865.

    Read at: PubMed
  • Published on 4/15/2023

    Salas M, Gossell-Williams M, Yalamanchili P, Dhingra S, Malikova MA, Aimer O, Junaid T. The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature. Biomark Insights. 2023; 18:11772719231164528. PMID: 37077840.

    Read at: PubMed
  • Published on 3/24/2023

    Malikova M.A. . 35th Annual Europe Meeting, Drug Information Association (DIA EUROPE 2023), March 24th, 2023, Basel, Switzerland. Abstract ID:101264. Risk-Based Quality and Safety Management in Clinical Trials with Combination Products in Global Regulatory Environment. 2023.

  • Published on 3/17/2023

    Akpoviroro O, Castagne-Charlotin M, Joyce NP, Malikova MA. Assessment of the Relationship Between Protocol Adherence, Study Complexity and Personnel in Surgical Clinical Trials. Ther Innov Regul Sci. 2023 Jul; 57(4):619-628. PMID: 36930415.

    Read at: PubMed
  • Published on 1/1/2023

    He Y, Shiu YT, Imrey PB, Radeva MK, Beck GJ, Gassman JJ, Northrup HM, Roy-Chaudhury P, Berceli SA, Cheung AK. Association of Shear Stress with Subsequent Lumen Remodeling in Hemodialysis Arteriovenous Fistulas. Clin J Am Soc Nephrol. 2023 Jan 01; 18(1):72-83. PMID: 36446600.

    Read at: PubMed
  • Published on 10/26/2022

    Malikova M.A., Cole A., Trifirò G.; Racagni G., Van Liew D., Webster P., Brahmbhatt T. Frontiers in Drug Safety and Regulation. Establishing patient safety monitoring in the benefit-risk paradigm for off-label and emergency use of medications for COVID-19: A pharmacovigilance perspective. EPub. https://doi.org/10.3389/fdsfr.2022.1038235. 2022; 1-6.

    Read at: Custom
  • Published on 10/14/2022

    Malikova M.A. The Symposium on Advanced Wound Care (SAWC). October 13-16th, 2022, Las Vegas, Nevada, USA.Abstract Book. Building Quality by Design into Wound Care Trials with Combination Products. 2022; 83-84.

    Read at: Custom
  • Published on 9/23/2022

    Palin K., V. Kugener V., Salas M., Malikova M., Price J., Webster P., Cole A., Ely D., Habibi S., Joshi P. 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities”. Am2P: A New Accredited Academic Training Program in Pharmacovigilance and Pharmacoepidemiology Designed for US, Canadian and Caribbean Healthcare Professionals. Drug Safety. 2022; (45):1275–1276.

    Read at: Custom
  • Published on 9/23/2022

    Malikova M., Webster P., Brahmbhatt T. 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23, September 2022 Verona, Italy. Establishing Patient Safety Monitoring in the Benefit-Risk Paradigm for Off-Label and Emergency Use of Medications for COVID-19: A Pharmacovigilance Perspective. Drug Safety. Drug Safety. 2022; (45):1199–1200.

    Read at: Custom

View 62 more publications: View full profile at BUMC

View all profiles